Key result
APOA5 c.56C>G variant linked to ~48% higher risk of metabolic syndrome in Caucasians.
Observational (n=3,124)
Yes
Answers are grounded in this paper and cite their sources.
Apolipoprotein A5 (APOA5) gene variants were reported to be associated with two components of metabolic syndrome (MetS): higher TG levels and lower HDL levels. Moreover, a recent Japanese case-control study found variant -1131T>C associated with MetS itself. Thus, our study systematically analyzed the APOA5 gene for association with lipid parameters, any other features of MetS, including waist circumference, glucose-related parameters, blood pressure, uric acid, and MetS itself in Caucasians. Ten polymorphisms were analyzed in a large fasting sample of the population-based Cooperative Health Research in the Region of Augsburg (KORA) survey S4 (n = 1,354; southern Germany) and in a second fasting sample, the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk (SAPHIR) study (n = 1,770; Austria). Minor alleles of variants -1131T>C, -3A>G, c.56C>G, 476G>A, and 1259T>C were significantly associated with higher TG levels in single polymorphism (P < 0.001) and haplotype (P <or= 6.6 x 10(-6)) analysis. Besides associations with lower HDL levels in SAPHIR (P <or= 0.001), there were no significant findings with any other features of MetS. Variant c.56C>G was associated with higher risk for MetS [odds ratio (95% confidence interval) = 1.43 (1.04, 1.99), P = 0.03 for KORA and 1.48 (1.10, 1.99), P = 0.009 for SAPHIR). Our study confirms the association of the APOA5 locus with TG and HDL levels in humans. Furthermore, the data suggest a different mechanism of APOA5 impact on MetS in Caucasians, as variant c.56C>G (not analyzed in the Japanese study) and not -1131T>C, as in the Japanese subjects, was associated with MetS.
No takes yet. Share an insight, caveat, or question.
Grallert et al. (2007) conducted an observational in Metabolic syndrome and dyslipidemia (n=3,124). APOA5 gene variants (specifically c.56C>G, -1131T>C, -3A>G, 476G>A, and 1259T>C) vs. Major allele / wild-type carriers was evaluated on Metabolic syndrome (MetS) and lipid parameters (TG and HDL levels) (OR 1.48, 95% CI 1.10-1.99, p=0.009). The APOA5 c.56C>G variant increased metabolic syndrome risk in Caucasians across both KORA and SAPHIR cohorts.
Synapse has enriched 10 related papers. Consider them for comparative context: